check_circleStudy Completed
Contraception
Bayer Identifier:
15346
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
INAS-FOCUS International Active Surveillance Study - Folate in Oral Contraceptives Utilization Study
Trial purpose
The study compares the risks of short- and long-term use of contraceptives containing drospirenone (DRSP) or dienogest (DNG)/ ethinylestradiol (EE) plus levomefolate calcium (metafolin) with the risks of short- and long-term use of other established oral contraceptives (OCs).
Key Participants Requirements
Sex
FemaleAge
NaN - N/ATrial summary
Enrollment Goal
82921Trial Dates
November 2010 - October 2019Phase
N/ACould I Receive a placebo
N/AProducts
BEYAZ (EE20/DRSP/L-5-MTHF, BAY98-7071)Accepts Healthy Volunteer
YesWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many locations, Canada | |
Completed | Many locations, Russia | |
Completed | Many locations, Ukraine | |
Completed | Many locations, United States |
Primary Outcome
- Absolute risk of venous thromboembolic eventsdate_rangeTime Frame:Up to 6 years
- Absolute risk of acute myocardial infarctiondate_rangeTime Frame:Up to 6 years
- Absolute risk of cerebrovascular accidentsdate_rangeTime Frame:Up to 6 years
Secondary Outcome
- Colorectal cancerdate_rangeTime Frame:Up to 6 years
- Other cancer entitiesdate_rangeTime Frame:Up to 6 years
Trial design
Trial Type
ObservationalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A